Blog | HemaCare

What Can Stem Cell Therapy Learn from Pharma Development? 

Jan 21, 2015 1:00:24 PM / by Maria posted in Assay Development, cancer immunotherapy, drug development, Innovation, research, stem cell therapy, Stem Cell Therapy

0 Comments

What lessons can stem cell therapy take from pharmaceutical development?
Image credit: Public health image library 18143
Read More

Challenges in Advancing Stem Cell Therapy

Jan 7, 2015 1:00:12 PM / by Maria posted in cancer immunotherapy, drug development, Innovation, research, stem cell therapy, Stem Cell Therapy, stem cells

0 Comments

Challenges facing stem cell therapy development can be overcome by turning to drug discovery
Read More

3D Stem Cell Models for In Vitro Skin Studies

Jul 16, 2014 1:00:14 PM / by Maria posted in drug screening, 3D model, 3D stem cell models, 3D tissue culture, animal testing, cosmetics, drug development, Independent validation, induced pluripotent stem cells, Innovation, mesenchymal, pluripotency, research, skin, stem cells, Uncategorized

0 Comments

It doesn’t get much trendier these days than either 3-dimentional (3D) or stem cells. Put the two together and you have cooler-than-cool 3D stem cell models, a topic pregnant with possibilities.  

Read More

BIO 2014 Partnering: Collaboration Brings Cures to the Clinic Faster

Jun 30, 2014 3:05:38 PM / by Maria posted in drug development, drug discovery, innovation, partnering, research

0 Comments

The Biotechnology Industry Organization (BIO) met in San Diego last week bringing together academic and industry leaders.  The goal of the meeting - to foster collaboration, promote innovation, bring cures to the clinic, and encourage economic growth. Some pretty intense objectives! How can such idealized goals be reached? There was a palpable energy around the answer: Partnering.

Read More

Engineering Hematopoietic Stem Cells for a One-Two Punch of Cancer Immunotherapy

Mar 26, 2014 6:16:13 AM / by Maria posted in PBCs, cancer, Cancer Immunology, cancer immunotherapy, cell therapy, chemotherapy, drug development, hematopoietic stem cells, HSCs, immunotherapy, Innovation, leukemia, lymphoma, Peripheral blood cells, research, stem cell therapy, stem cells, T cells

0 Comments

In Part I of this series we introduced T cell based immunotherapy and in Part II we discussed how chimeric antigen receptors (CARs) expressing T cells can be even more potent. In Part III below, we expand this concept further by covering hematopoetic stem cells and additional ways they can be engineered for promising immunotherapy of cancer and leukemia.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts